A system approach to improving guideline-directed therapy for cardio-renal-metabolic conditions: The "beyond diabetes" initiative

• Main Authors: Benjamin J. Hirsh (Author), Jamie S. Hirsch (Author), Hosam Hmoud (Author), Spencer Weintraub (Author), Agnes Cha (Author), Martin Lesser (Author), Xueqi Huang (Author), Yan Yan Sally Xie (Author), Rachel Nahrwold (Author), John Joshua (Author), Jennifer Scanlon (Author), Thomas Galella (Author), Varinder Singh (Author), Eugenia Gianos (Author)
• Format: Book
• Published: Elsevier, 2023-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objective: Despite demonstrating improvements in cardiovascular disease, kidney disease, and survival outcomes, guideline-directed antihyperglycemic medications such as sodium-glucose cotransporter 2 inhibitors (SGLT2i) and glucagon-like-peptide-1 receptor agonists (GLP1-RA), are underutilized. Many...